Determination of immunogenic proteins in biopharmaceuticals by UHPLC-MS amino acid analysis.

Amino acids Biopharmaceuticals Derivatization Etanercept Keyhole limpet hemocyanin Mass spectrometry Quality control Ultra high-performance chromatography

Journal

BMC chemistry
ISSN: 2661-801X
Titre abrégé: BMC Chem
Pays: Switzerland
ID NLM: 101741142

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 17 01 2019
accepted: 02 05 2019
entrez: 7 8 2019
pubmed: 7 8 2019
medline: 7 8 2019
Statut: epublish

Résumé

Nowadays, there is a growing interest in innovative and more efficient therapeutics-biopharmaceuticals, based on peptides or proteins. There are increased demands on quality control of such therapeutics. One of the methods usually used for characterization and quantification of biopharmaceuticals is amino acid analysis. In this work, a modern advanced analytical method based on precolumn derivatization and reversed-phase ultra high-performance liquid chromatography in combination with single quadrupole mass spectrometer was developed for amino acid analysis in different protein samples-model sample of bovine serum albumin, sample of strong immunogenic protein keyhole limpet hemocyanin, and sample of drug etanercept present in commercially available biopharmaceutical Enbrel. The method used isotopically labeled internal standards and was validated according to the International Council for Harmonisation guideline. The developed method was characterized by favorable performance and validation parameters, such as time of analysis (6 min), specificity, linearity (r

Identifiants

pubmed: 31384811
doi: 10.1186/s13065-019-0581-z
pii: 581
pmc: PMC6661756
doi:

Types de publication

Journal Article

Langues

eng

Pagination

64

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

Micron. 1999 Dec;30(6):597-623
pubmed: 10544506
Eur Urol. 2000;37 Suppl 3:24-33
pubmed: 10828684
J Chromatogr A. 2002 Mar 8;949(1-2):99-124
pubmed: 11999763
J Biomol Tech. 2004 Dec;15(4):317-24
pubmed: 15585828
J Investig Dermatol Symp Proc. 2007 May;12(1):38-45
pubmed: 17502868
Rapid Commun Mass Spectrom. 2009 May;23(10):1483-92
pubmed: 19350529
J Pharm Biomed Anal. 2010 Apr 6;51(5):1175-9
pubmed: 20022725
Anal Chem. 2010 Jan 15;82(2):548-58
pubmed: 20038084
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 May 15;879(17-18):1345-52
pubmed: 21195681
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Sep 15;879(26):2695-703
pubmed: 21852206
Anal Chem. 2011 Oct 1;83(19):7523-30
pubmed: 21879760
Methods Mol Biol. 2012;828:13-28
pubmed: 22125132
J Clin Biochem Nutr. 2012 Nov;51(3):248-9
pubmed: 23170055
Anal Bioanal Chem. 2013 Oct;405(25):8073-81
pubmed: 23719935
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Sep 1;934:79-88
pubmed: 23911539
Anal Bioanal Chem. 2013 Oct;405(25):7957-92
pubmed: 24013667
J Forensic Sci. 2014 Mar;59(2):364-70
pubmed: 24261898
Meat Sci. 2014 Mar;96(3):1177-84
pubmed: 24334038
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Aug 1;964:180-90
pubmed: 24842860
Alzheimers Res Ther. 2014 Aug 01;6(4):44
pubmed: 25478017
Clin Chim Acta. 2015 Mar 10;442:73-4
pubmed: 25598409
Analyst. 2015 Mar 21;140(6):1965-73
pubmed: 25671319
J Pharm Biomed Anal. 2015 Oct 10;114:426-32
pubmed: 26119505
Biomed Chromatogr. 2016 Jun;30(6):983-5
pubmed: 26419504
Anal Biochem. 1989 Feb 1;176(2):269-77
pubmed: 2662808
J Inherit Metab Dis. 2016 Sep;39(5):651-660
pubmed: 27099181
J Sep Sci. 2017 Apr;40(7):1482-1492
pubmed: 28145078
Anal Chem. 2017 Feb 21;89(4):2478-2487
pubmed: 28194962
Sci Rep. 2017 May 3;7(1):1423
pubmed: 28469184
Brain Res. 2017 Oct 15;1673:72-77
pubmed: 28779977
J Pharm Biomed Anal. 2017 Oct 25;145:751-757
pubmed: 28810230
J Pharm Biomed Anal. 2018 Jan 5;147:35-49
pubmed: 28927726
Plant Methods. 2018 Jan 19;14:8
pubmed: 29375649
J Chromatogr A. 2018 Mar 9;1540:55-67
pubmed: 29448995
J Pept Sci. 2018 Aug;24(8-9):e3113
pubmed: 30009393
Mol Pharm. 2018 Nov 5;15(11):4947-4962
pubmed: 30240216
Amino Acids. 2019 Feb;51(2):295-309
pubmed: 30327888
J Chromatogr A. 1998 Nov 27;826(2):109-34
pubmed: 9917165

Auteurs

Juraj Piestansky (J)

1Department of Pharmaceutical Analysis and Nuclear Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, Odbojarov 10, 832 32 Bratislava, Slovak Republic.
2Toxicological and Antidoping Center, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, 832 32 Bratislava, Slovak Republic.

Jaroslav Galba (J)

1Department of Pharmaceutical Analysis and Nuclear Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, Odbojarov 10, 832 32 Bratislava, Slovak Republic.
3AXON Neuroscience R&D, Dvorakovo Nabrezie 10, 845 10 Bratislava, Slovak Republic.

Dominika Olesova (D)

4Institute of Neuroimmunology, Slovak Academy of Science, Dubravska Cesta 9, 845 10 Bratislava, Slovak Republic.

Branislav Kovacech (B)

3AXON Neuroscience R&D, Dvorakovo Nabrezie 10, 845 10 Bratislava, Slovak Republic.
4Institute of Neuroimmunology, Slovak Academy of Science, Dubravska Cesta 9, 845 10 Bratislava, Slovak Republic.

Andrej Kovac (A)

3AXON Neuroscience R&D, Dvorakovo Nabrezie 10, 845 10 Bratislava, Slovak Republic.
4Institute of Neuroimmunology, Slovak Academy of Science, Dubravska Cesta 9, 845 10 Bratislava, Slovak Republic.

Classifications MeSH